Did you know that manual document reconciliation between trial systems consumes at least one-third of clinical data managers' and clinical research associates’ time?
This means your highly trained professionals are spending their days chasing files between platforms rather than moving science forward.
Medable’s TMF Agent takes on the high-volume work of organizing and filing trial documents across studies. Your team reviews, approves, stays in control where it matters, and gets their time back.
That shift is a game changer and frees up real strategic capacity.
DM this account to learn more! 📥
________
#clinicalresearch #TMF #clinicaltrials #agenticAI
"We need better data before we can use AI." This is one of the most expensive assumptions in clinical development.
If you're holding off until every system is standardized and every dataset is perfectly aligned, you could be waiting for years.
AI agents can create value across fragmented clinical data today.
Register for tomorrow's session with @ICONplc and @LakefrontBio to find out more: https://t.co/IqaBb35HB4
One of the most overlooked challenges in healthcare is that clinical trials still run on workflows designed for a different era. Meanwhile, patients are waiting.
By bringing together Medable's global agent platform and @googlecloud's AI infrastructure, we're creating new ways to streamline the operational side of drug development, from site activation to study execution to close-out & reporting.
The vision is simple: Let experts focus on expertise. Let agents handle the admin. That's how we radically accelerate R&D timelines.
Learn more from our CEO @LongmireMD below!
Ambition is easy. Evidence is harder. 💯
Tomorrow, at Roche's Clinical Trial Innovation Summit, Medable's Andrew Mackinnon will walk through exactly how agentic AI moves from roadmap to reality in clinical research. He'll cover real deployments, in regulated environments, with outcomes you can actually point to.
If you're attending this event and serious about where your organization goes next with AI, add this session to your calendar today! 📅
________
#clinicaltrials #clinicalresearch #healthcare #AIagents
Oncology trials may screen 1 to 5 patients a day. Vaccine trials can screen and enroll up to 1,000 participants per day.
That level of scale demands rapid activation across multiple sites, real-time safety monitoring from day one, and an eCOA platform built to keep up.
See how Medable helped a top-5 pharma launch the infrastructure for true vaccine mega-trials, creating a blueprint now running across 3 additional studies, including one with 50,000 patients and 428 sites. 👇
Read here: https://t.co/l0buRVrjXG
________
#clinicaltrials #clinicalresearch #vaccines #healthcare
Poorly designed caregiver workflows don't just frustrate families; they create data problems downstream, including duplicate entries and missing submissions. Medable's caregiver solution solves this challenge at the source with one app, one record, and one submission at a time, because your eCOA is only as good as the data going into it.
________
#clinicaltrials #clinicalresearch #healthcare #eCOA
Angie Maurer, VP of AI-enabled clinical development at Medable, explains the 3 structural barriers that kept protocol digitization out of reach—and why the convergence of LLMs, industry standards, and validated environments has finally changed the equation.
Watch here: https://t.co/sSlffalgTx
________
#clinicaltrials #clinicalresearch #healthcare #drugdevelopment
Do you think your organization’s data is ready for AI or AI agents? Most sponsors and CROs instinctively answer, "Not yet.” But that assumption is increasingly being challenged.
In this upcoming session with @ICONplc and @LakefrontBio, we will explore how study teams can move forward with their current data landscape.
Attendees will learn how agentic AI safely delivers measurable value across clinical trials, reduces cognitive and operational burden, and generates immediate impact while strengthening data foundations over time.
👉 Secure your spot here: https://t.co/IqaBb35HB4
CRAs are logging into 13 systems to understand what's happening at a site, TMF teams are buried in document chasing, and PI reviews are taking too long to pull together.
This week, Angie Maurer and Wade Strzinek are at DIA 2026 discussing how purpose-built AI agents can support these manual workflows, taking the operational weight off teams who have better things to do.
10x the value chain for digital data flow (DDF) output! 🙌
As the industry moves toward more adaptive and real-time data clinical trial models, Medable’s DDF Agent helps establish the infrastructure needed for continuous protocol evolution. Changes made to the protocol after approval can automatically propagate across connected documents, workflows, and systems, reducing operational burden and helping organizations respond more rapidly to emerging study insights.
Start studies faster, keep critical documents aligned, and stay inspection-ready by default.
Send us a DM for a demo! 📥
Today, we announce our Digital Data Flow (DDF) Agent, which automatically transforms static clinical trial protocols into structured, machine-readable data that can be continuously used across the clinical development lifecycle.
Traditionally, clinical trial protocols are static documents that require extensive manual interpretation and re-creation across many downstream systems. Medable’s DDF Agent converts protocol information into a CDISC USDM 4.0, standardized, structured JSON data format, which is foundational for automated and dynamic readiness and adaptivity throughout a clinical trial.
👉 Find out more here: https://t.co/g0WLFutWa8
________
#clinicaltrials #clinicalresearch #AIagents #drugdevelopment
Billions of dollars, years of development, and patient outcomes can hinge on the decisions made in the final stages of a program.
Next week in Cambridge, MA, our CCO Alison Holland sits down with the CEOs of Formation Bio and Saghmos Therapeutics, the president of ReAlta Life Sciences, and Takeda's head of neuroscience to discuss "Advancing Late-Stage Assets."
If you're at the Koch Institute on June 15-16 for MIT CEO, this is a conversation worth catching.
Add the session to your calendar here: https://t.co/wvomY46FQy
________
#clinicaltrials #clinicalresearch #healthcare #drugdevelopment
Onboarding. Integration. Governance. Change management.
Our Agentic Accelerator Program gives sponsors and CROs everything they need to deploy AI agents from day one, with a team that has skin in the game on your clinical outcomes.
Go from zero to scaled in weeks, not years. Learn more here: https://t.co/hYeUelXCOw
________
#clinicaltrials #clinicalresearch #AIagents #drugdevelopment
To transform clinical development, we must increase both productivity and velocity. Find out how a top-10 global sponsor partnered with Medable to expand the number of oncology trials they could concurrently conduct and accelerate their timelines. 📈
👉 Access the case study here: https://t.co/lVbk3JL7Jy
________
#clinicaltrials #clinicalresearch #oncology #healthcare #clinicaldevelopment
Generic AI: great for emails and task completion. Not so great for clinical trials.
R&D is too complex, too regulated, and too high-stakes for software that wasn't built for it.
Sponsors and CROs are noticing, and they're making the switch. 👌
The difference between hoping for better study outcomes and driving them?
Control. 💯
Legacy eCOA keeps critical decisions hidden behind a vendor black box. Medable eCOA empowers sponsors to succeed with complete transparency, streamlined global deployments, and the ability to shape and validate execution at every step.
See what's possible at https://t.co/tlAJkqdTK8!
Oncology science isn't slowing down 🔬. The sponsors and CROs who lead the next decade will be those who have built the operational infrastructure to keep up: moving quickly, adapting as protocols evolve, and managing complex portfolios without the overhead consuming the gains.
Breakthroughs still need to be executed, and execution is an operational challenge just as much as a scientific one.
The future belongs to those who take action now. Learn about the new blueprint for cancer research here: https://t.co/xuqV5QhVvs
________
#clinicaltrials #clinicalresearch #oncology #healthcare
Clinical development is constrained by human bandwidth, not intent or expertise. Every hour spent chasing documents, reconciling data, or managing workflows is an hour spent not advancing science.
Enter Agent Studio, a unified platform with pre-built AI agents that continuously monitor trial activity, surface emerging risks, and deliver actionable recommendations across CTMS, EDC, and eTMF. With configurable automation and human oversight built in, study teams can move faster and achieve more without sacrificing control or safety.
Need something more specialized? Through our co-development program, we partner with you to design, refine, and deploy custom agents tailored to your unique trial requirements.
Visit https://t.co/tlAJkqdTK8 to learn more!
Currently, there are 10,000 human diseases without treatment. This issue does not resolve itself simply because molecules are now improving. We must also transform clinical trials.
For true progress, pharmaceutical and biotechnology companies need to be willing to rethink the operating models they’ve relied on for decades.
This is where agentic AI enters the picture.
👉 Hear from Medable CEO, @LongmireMD, about innovating to meet the demands of 21st-century R&D in her new article for @FastCompany: https://t.co/mBk3I1Egrj
________
#clinicaltrials #clinicalresearch #healthcare #agenticAI #clinicaldevelopment